Hot Deals:
adtech 45.00 (4.65 %) agarwal bolts 1,200.00 (0.00 %) amol minechem 601.00 (0.17 %) anand i-power 20.00 anglo french drugs 745.00 (-0.67 %) apl metals 41.00 (2.24 %) arkfin investments 50.00 arohan 145.00 (3.57 %) assam carbon 200.00 (2.56 %) atlas copco 10,000.00 (1.01 %) auckland international 129.00 (-0.77 %) av thomas 16,800.00 (0.00 %) axles 315.00 (3.96 %) balmer lawrie 202.00 (1.00 %) bharat hotels 290.00 (3.57 %) bima mandi 500.00 (-10.71 %) bira 605.00 (-0.82 %) boat 1,275.00 (2.00 %) c & s electric 555.00 (0.91 %) cable corporation 13.10 (0.77 %) capgemini 11,400.00 (-0.87 %) care health 180.00 (-2.70 %) carrier aircon 400.00 (2.56 %) cial 250.00 (2.04 %) csk 174.00 (-1.14 %) dalmia refract 152.00 (1.33 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 425.00 (2.66 %) electronica plastic 2,100.00 (-0.99 %) elgi ultra 400.00 elofic 2,070.00 (-1.43 %) esl steel 30.00 (3.45 %) fincare business 65.00 (1.56 %) fincare sfbl 202.00 (1.00 %) finopaytech 155.00 (-3.13 %) flipkart india 231,001.00 (0.00 %) frick india 10,500.00 (3.96 %) gkn driveline 1,300.00 (4.00 %) go digit general insurance ltd 354.00 (1.14 %) godavari bio 71.00 (1.43 %) hdb financial 820.00 (-0.61 %) hdfc ergo 370.00 (1.70 %) hdfc securities 10,650.00 (0.47 %) hella india 810.00 (1.25 %) hero fincorp 1,550.00 (1.64 %) hexaware 780.00 (0.39 %) hicks 1,450.00 (2.11 %) hira ferro 155.00 (3.33 %) honeywell electrical 3,900.00 (2.63 %) ikf finance 210.00 (-2.78 %) incred financial 109.00 (3.81 %) incred holdings 120.00 (8.11 %) india carbon 900.00 (6.01 %) india exposition 135.00 (-0.74 %) indian potash 3,400.00 (3.03 %) indo alusys 25.75 (-0.96 %) indofil 700.00 (1.45 %) infinite computer 405.00 (1.25 %) inkel 17.00 (6.92 %) ixigo 152.00 (4.83 %) jana small finance bank 75.00 kel 615.00 (-1.60 %) kial 125.00 (0.00 %) klm axiva 15.00 (-6.83 %) kurlon limited 625.00 (2.46 %) lava 80.00 (-3.61 %) mahindra rural mrhfl 100.00 manipal housing 72.50 (0.69 %) manjushree technopack 1,000.00 (-0.99 %) martin & harris 990.00 (7.03 %) merino 3,450.00 (4.55 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 425.00 (2.66 %) mobikwik 595.00 (-1.65 %) mohan meakin 1,900.00 (-1.04 %) mohfl 13.50 (-1.82 %) msei 1.35 (-6.90 %) msil 41.00 (-2.38 %) nayara energy 410.00 (2.50 %) nayara energy ncd 285.00 (1.79 %) ncdex 275.00 ncl buildtek 260.00 (-1.89 %) ncl holdings 71.00 (1.43 %) nsdl 700.00 nse 4,500.00 (-4.26 %) orbis financial 255.00 (2.41 %) oswal minerals 60.10 (-1.48 %) otis 3,750.00 (-1.32 %) oyo 61.00 (-11.59 %) panasonic appliances 211.00 (0.48 %) paymate india 530.00 (1.92 %) pharmeasy 10.00 (0.00 %) pharmed limited 470.00 (4.21 %) philips domestic 575.00 (3.60 %) philips india 925.00 (0.54 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 300.00 (-1.64 %) rapido 16,650.00 (0.03 %) rasoi 31,500.00 (0.32 %) reliance gic 410.00 (2.50 %) resins plastics 415.00 (-1.89 %) ring plus aqua 405.00 (0.25 %) rrl 1,275.00 (2.00 %) sab miller 380.00 (1.33 %) sbi amc 1,600.00 (0.95 %) sbi general insurance 600.00 (3.45 %) scottish assam 440.00 (-1.35 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,350.00 (-2.17 %) smile microfinance 54.00 (3.85 %) sportskeeda 3,303.00 sterlite power 510.00 (-1.92 %) studds 999.00 (-0.10 %) svsml 320.00 (-3.03 %) swiggy 361.00 (0.28 %) t stanes 755.00 (2.72 %) tata capital 790.00 (-2.23 %) teesta agro 77.00 (-6.21 %) trl krosaki 1,300.00 (-1.89 %) utkarsh coreinvest 330.00 (-0.90 %) vadilal dairy 10.00 vikram solar 220.00 (-4.35 %) waree energies 1,900.00 (1.33 %)
×

Healthcaps India Share Price

Company Name
Healthcaps India Limited
Scrip Name
Healthcaps India
Last Traded Price
230.00
+ 1.32 %
Sector
Healthcare
PAN No.
AAACC5021C
Face Value
10
No. of Outstanding Shares
4,037,190
EPS
73.845
PE ratio
3.115
Market Capitalization
92.86 Crore
Book value
405
P/BV
0.5679
ISIN No.
INE936K01016
Available on
nsdl
ROFR Require
No

About HEALTHCAPS INDIA LIMITED Unlisted Shares

HEALTHCAPS INDIA LIMITED was incorporated on 06 December 1982. It is classified as a Non-govt company and is registered at Registrar of Companies, Chandigarh. Healthcaps India Limited is a WHO-GMP Certified Company and is in the production of Empty Hard Gelatin Capsule Shells (I.P. / B.P.). Healthcaps India Limited products are widely used in the encapsulation of drugs, vitamins, antibiotics, etc, whether in powder or in pellet form by major pharmaceutical companies in India and abroad. Healthcaps India Limited also manufactures BSE/TSE-free EHG Capsules using EDQM-approved gelatin. With the objective of creating an eco-friendly environment, with stringent quality control checks in place, the company chose the open spaces in Fatehpur, Punjab, 60 km from Chandigarh for its manufacturing facility. And to facilitate easy interaction with clients, it has established offices in Chandigarh, New Delhi, and Mumbai. The company's vision is to become a global leader in the manufacture of empty capsules, setting benchmarks in quality and regulatory systems, and creating new market spaces with a focus on innovation.

 

HEALTHCAPS INDIA INCORPORATION DETAILS

HEALTHCAPS INDIA CIN

U74899PB1982PLC050929

HEALTHCAPS INDIA Registration Date

06.12.1982

Category/Sub-category of the Company

 Public Company

Limited by shares

A company having share capital

Address of the Registered office and contact details of Healthcaps India Limited

Tehsil Balachaur, District -SBS Nagar

(Nawanshahr), Punjab – 144522

Telephone: 01881-273637

Name, Address, and Contact Details of

Registrar and Transfer Agent, if any

M/s Beetal Financial & Computer Services Pvt Ltd

Beetal House, 3rd Floor,99 Madangir,

Behind Local Shopping Center, Near Data Harsukhdas Mandir New Delhi- 110062

 

PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY

Name and Description of main products/services

% to the total turnover of the Company

Manufacture and Sale of Empty Hard Gelatin and HPMC Capsules

100%

 

HEALTHCAPS INDIA BOARD OF DIRECTORS

Mr. Chiranjiv Singh (Managing Director)

Mrs. Hariti Singh (Whole Time Director)

Mr. I. S. Bindra (Director)

Mr. Gurucharan Singh (Independent Director)

Mr. ArunBhakoo (Independent Director)

 

PARTICULARS OF HEALTHCAPS INDIA SUBSIDIARY AND ASSOCIATE COMPANIES

HEALTHCAPS INDIA LIMITED does not have any subsidiary or associate company.

 

 

SHAREHOLDING PATTERN of HEALTHCAPS INDIA (As of 31-03-2020)

S. No.

Shareholder’s Name

Number of shares

% of total Shares of the company

1

Chiranjiv Singh (Promoter)

26,50,468

65.65%

2

Hariti Singh (Promoter)

4,62,462

11.46%

3

Public Shareholding

9,24,260

22.89%

 

Total

40,37,190

100%

 

INDUSTRY OUTLOOK

Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and the 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of the global demand for various vaccines, 40% of the generic demand in the USA, and 25% of all medicines in the United Kingdom. Excellent Research and development, low cost of labor, availability of management and technical personnel, and local equipment availability have helped India to manufacture pharma products at a very low cost.

The Indian healthcare market may see a 3 fold jump in terms of value to reach                 US$ 372 billion by FY 2022. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID-19. India aims to achieve vaccination for COVID-19 of 30 Crore people in the next few months.

Export of pharmaceutical products from India stood at US$ 16.8 billion in FY 2020 and US$ 2.07 billion in the month of October 2020. In the first 3 quarters of FY 2021, India exported pharmaceuticals worth US$ 15.86 billion. India supplied around 45 tons and 400 million tablets of hydroxychloroquine to around 114 countries globally to treat COVID-19 patients in the initial stage of the COVID-19 pandemic. Exports in FY 2021 of Indian pharma products are expected to cross US$ 24 billion, increasing by over 16% when compared to FY 2020.

After the onset of COVID-19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector.

 

PROFIT & LOSS STATEMENT OF HEALTHCAPS INDIA LIMITED (In Rs. Lakhs) 

PARTICULARS

2020

2019

2018

Revenue from Operations

10,814.52

10,217.36

8,278.14

EBITDA

1,868.31

2,101.49

950.15

EBITDA margins

17.22%

20.53%

11.45%

Finance Cost

431.04

340.51

222.11

Depreciation

357.13

328.43

277.41

Other Income

35.01

16.34

21.17

Exceptional Items

2.60

(12.26)

(0.41)

Profit Before Tax

1,117.74

1,436.63

1,056.70

Total Tax

291.89

428.11

394.46

Profit After Tax (PAT)

825.85

1,008.52

662.24

PAT margin

7.61%

9.85%

7.98%

EPS (Rs.)

20.46

24.98

16.40

 

BALANCE SHEET OF HEALTHCAPS INDIA LIMITED (In Rs. Lakhs)

PARTICULARS

31st March 2020

31st March 2019

ASSETS

   

NON CURRENT ASSETS

   

Tangible assets

7,578.53

6,764.13

Intangible assets

1.89

1.03

Long-term Loans & Advances

195.40

248.14

Other non-current assets

14.40

1.69

TOTAL NON-CURRENT ASSETS

7,790.22

7,014.98

CURRENT ASSETS

   

Inventories

2,214.93

1,725.03

Trade receivables

4,121.15

3,954.81

Cash and cash equivalent

297.48

276.71

Short-term Loans & Advances

470.53

461.50

Other current assets

14.96

15.33

TOTAL CURRENT ASSETS

7,119.05

6,433.39

TOTAL ASSETS

14,909.27

13,448.37

EQUITY AND LIABILITIES

   

EQUITY

   

Equity Share Capital

403.72

403.72

Other Equity

6,290.86

5,493.67

TOTAL EQUITY

6,694.58

5,897.39

LIABILITIES

   

NON CURRENT LIABILITIES

   

Long term borrowings

1,745.63

1,736.48

Provisions

477.57

400.25

Tax liabilities

846.28

796.30

TOTAL NON-CURRENT LIABILITIES

3,069.48

2,933.03

CURRENT LIABILITIES

   

Trade payables

1,191.08

1,109.76

Short-term Borrowings

2,106.94

1,905.39

Provisions

238.28

309.59

Other current liabilities

1,608.90

1,293.21

TOTAL CURRENT LIABILITIES

5,145.21

4,617.95

TOTAL LIABILITIES

8,214.69

7,550.99

TOTAL EQUITY AND LIABILITIES

14,909.27

13,448.37

 

HEALTHCAPS INDIA DIVIDEND HISTORY

Particulars

2020

2019

2018

Dividend (final + interim) (In Rs.)

Nil

Nil

Nil

 

PERFORMANCE OF THE HEALTHCAPS INDIA

Revenue from Operations of the company in FY 2020 was Rs. 10,814.52 Lakhs, as against Rs. 10,217.36 Lakhs in FY 2019. Revenue from Operations of the company increased by Rs. 597.16 Lakhs, which is about a 6% increase.

EBITDA of the company decreased by 11.10% from Rs. 2,101.49 Lakhs in FY 2019 to Rs. 1,868.31 Lakhs in FY 2020. EBITDA margins decreased from 20.53% in FY 2019 to 17.22% in FY 2020.

In FY 2019, the company incurred a profit of Rs. 1,008.52 Lakhs. In FY 2020 the company made a profit of Rs. 825.85 Lakhs, i.e. decrease of 18.11% 

The Current Ratio of the company as of 31st March 2020 was 1.38.

The debt-to-equity ratio of the company as of 31st March 2020 was 0.57.

The book value per share of the company as of 31st March 2020 stood at Rs. 165.82.

Annual Report

Healthcaps India Annual Report 2022-23

Download

Healthcaps India Annual Report 2021-22

Download

Corporate Actions

Reduction of Capital 25th August, 2023

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha